|
Either way, prognosis is not good.. Now to your questions.... 1. The maximum average survival rate for someone with metastatic malignant melanoma Stage III is 2 years... However, if the WHO staging is being used, then average survival rate is from 6-15 months...
|
en.allexperts.com/q/Oncology-General-Cancer-978/Metasta...
en.allexperts.com/q/Oncology-General-Cancer-978/Metastatic-Malignant-Melanoma.htm
|
|
|
Melanoma - Wikipedia, the free encyclopedia
|
|
Melanoma (pronounced /ˌmɛləˈnoʊmə/ ( listen) ) is a malignant tumor of melanocytes which are found predominantly in skin but also in the bowel and the eye (see uveal melanoma). It is one of the...
en.wikipedia.org/wiki/Melanoma
|
|
|
This retrospective study sought to evaluate the impact of IL-6 concentration on time to progression in advanced melanoma. ... Taken together, our results showed that serum IL-6 level could be considered a predictive marker of recurrent disease in metastatic malignant melanoma.
|
www.medscape.com/medline/abstract/14660055
|
|
|
The degree of mononuclear cell infiltration in primary tumours has been reported to correlate with a favourable prognosis. ... Twenty-one patients with systemic and 20 with regional metastatic malignant melanoma were studied before initiation of IFN-alpha treatment.
|
www.medscape.com/medline/abstract/8845294
|
|
Neoplastic transformation of melanocytes gives rise to malignant melanoma, a form of skin cancer. Once histopathology confirms the diagnosis, the tumor is staged to determine prognosis and treatment. ... Metastatic Melanoma Treatment; The prognosis of metastatic melanoma is dismal. Several large medical series...
|
www.hemispherx.net/content/ftp/metastatic.htm
www.hemispherx.net/content/ftp/metastatic.htm
|
|
Malignant melanoma currently accounts for approximately 1% of all cancer deaths. ... PROGNOSIS; Many factors are known to predict risk in patients with melanoma including Breslow depth, ... At present, after 20 years of experimentation, dacarbazine (DTIC) is the only agent approved by the FDA for treatment of metastatic melanoma,
|
www.cancernews.com/articles/melanomas.htm
www.cancernews.com/articles/melanomas.htm
|
|
The slides and reports of 135 departmental pathology consultations of patients referred to a major cancer center with a diagnosis of primary cutaneous invasive malignant melanoma were examined. ... We evaluated CD10 expression in tumor and stromal cells in 70 biopsies with primary and 28 with metastatic malignant melanomas.
|
www.thedoctorsdoctor.com/diseases/melanoma_prognosis.ht...
www.thedoctorsdoctor.com/diseases/melanoma_prognosis.htm
|
|
While melanoma accounts for roughly 4% of all skin cancers, it is responsible for more than 74% of skin cancer deaths. In the United States, one person each hour dies from metastatic melanoma. Treatment of melanoma ... Whether the melanoma subtype affects the overall prognosis remains controversial. ... More on Malignant Melanoma...
|
emedicine.medscape.com/article/1100753-overview
|
|
Malignant melanomas usually present at 2 extremes: at one end of the spectrum are patients with small skin lesions that are easily curable by surgical resection and at the other are patients with widely metastatic disease, in whom the therapeutic options are limited and prognosis is nil, ... Stage IV: Melanoma metastatic to skin,
|
emedicine.medscape.com/article/280245-overview
|
|
